The system is designed to shorten scan times, which may be better for people who struggle to stay still or have claustrophobia, and to detect more subtle abnormalities.
GE Healthcare’s head-only MRI scanner cleared by the FDA Read More »
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the downward trend seen as the COVID-19 pandemic eased.
FDA breakthrough device decisions rebound after recent declines Read More »
Despite recent enthusiasm around the PD-1/VEGF space, BMO Capital Markets analyst Evan Seigerman noted that Merck’s pact with LaNova Medicines is more “conservativism” on the pharma’s part, rather than confirmatory of recent data in the drug class.
Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal Read More »
Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic leukemia after Bristol Myers Squibb’s Breyanzi was approved in the indication earlier this year.
Allogene Bows to BMS in Leukemia, Ending Phase I CAR T Enrollment Read More »
Plus, communication errors that cost job offers and how to craft a LinkedIn “About” section
Career Coach: How to Boost Your Job Application by Networking Read More »
Following strong treatment response data for Adaptimmune’s lete-cel, the biotech is planning to initiate a rolling BLA submission to the FDA, set to start by the end of 2025.
Adaptimmune Plots Path to FDA as Sarcoma Cell Therapy Aces Pivotal Trial Read More »
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene therapy Kebilidi for AADC deficiency. It is the first approved gene therapy to be delivered directly to the brain.
PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets Ultrarare Disease Read More »
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster potential for the antibody-drug conjugate.
GSK Builds Case for Blenrep with Multiple Myeloma OS Data That Bests J&J’s Darzalex Read More »
Las enfermedades de Niemann Pick son un grupo de enfermedades genéticas raras relacionadas con la acumulación de lípidos o grasas en los lisosomas, unos orgánulos celulares que actúan como centros de reciclaje, digiriendo moléculas complejas y desechando mat …
Hay hongos y gusanos nemátodos que perjudican seriamente a vegetales muy comunes en los campos agrícolas. Una investigación reciente ha dado ahora con un modo de combatirlos que no ocasiona los problemas de contaminación y otros efectos secundarios provocados por otras su …
